Belgium· BE-AMP-SAM099592-00
Minipress 5 mg
A prazosin product containing prazosin hydrochloride, registered in Belgium by Pfizer. The same ATC class is registered in 9 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Prazosin is registered in 9 of 19 countries.
Countries holding a registration under ATC C02CA01 (prazosin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 4 of them publish a price we can compare per daily dose
Prazosin · ATC C02CA01
9 / 19 countries
- Belgiumprice
- Canada
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Prazosin Hydrochloride
- Manufacturer
- Pfizer
- Country
- Belgium (BE)
- ATC code
- C02CA01
- ATC class
- Prazosin
- Defined daily dose
- 5 mg, O
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 2
- be_apb0057752
- be_apb0711861
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
98 interactions on record for prazosin.
Graded by severity as the source publishes them — 78 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Prazosin · interactions on record
98 records
- 78 moderate
- 20 info
Most severe, free to view
- ThiethylperazinA04AB03moderate
- DiphenhydraminA04AB05moderate
- DronabinolA04AD10moderate
- NabiloneA04AD11moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Prazosin in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesPrazosinLannett Company, Inc.
- United KingdomAlphavase 1 tabletsAshbourne Pharmaceuticals Ltd
- FinlandPatsolinSchering Oy
- NorwayAlpress LPPfizer
- CanadaAPO-PRAZOAPOTEX INC
- SpainMINIPRES 1 mg COMPRIMIDOSPfizer S.L.
- FranceALPRESS L.P. 2,5 mg, comprimé osmotique à libération prolongéePFIZER HOLDING FRANCE
- IrelandHypovase 0.5mg TabletsPfizer Healthcare Ireland Unlimited Company
Authorised across Europe · EMA
The same active substance is authorised in 6 EEA countries. Names it is sold under:
- Cyprus · Atodel
- Spain · Minipres
- Finland · Pratsiol
- France · Alpress L.P.
- United Kingdom (Northern Ireland) · Hypovase
- Ireland · Hypovase
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/b3a37107-6e80-463d-bfcc-3fc1736d952c GET /v1/drugs/b3a37107-6e80-463d-bfcc-3fc1736d952c?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"source": "afmps",
"status": "REVOKED",
"name_en": "Minipress 5 mg",
"name_fr": "Minipress 5 mg",
"name_nl": "Minipress 5 mg",
"amp_code": "SAM099592-00",
"strengths": [
"5.4760",
"5.4760",
"5.0000",
"5.0000",
"0.6880"
],
"pack_count": 2,
"substances": [
"Prazosin Hydrochloride",
"Prazosin",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Prazosin",
"authorisation_numbers": [
"BE099592"
]
}See everything about prazosin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.